Newmont Co. (NGT.TO) – What Are Analysts Saying About This Stock?
Newmont Co. (TSE:NGT – Get Free Report) has been assigned an average rating of “Strong Buy” from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and six have assigned a strong buy rating to the company. Separately, Stifel Nicolaus raised […]
Yesway, Inc. (YSWY) – What Are Researchers Saying About This Stock?
Yesway, Inc. (NASDAQ:YSWY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven brokerages that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, three have given a buy rating and three have […]
Fate Therapeutics, Inc. (FATE) – What Are Investment Firms Saying About This Stock?
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) has received an average rating of “Moderate Buy” from the six research firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. […]
Houlihan Lokey, Inc. (HLI) – What Are Analysts Saying About This Stock?
Shares of Houlihan Lokey, Inc. (NYSE:HLI – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price […]
Monarch Casino & Resort, Inc. (MCRI) – What Are Researchers Saying About This Stock?
Shares of Monarch Casino & Resort, Inc. (NASDAQ:MCRI – Get Free Report) have received an average rating of “Moderate Buy” from the seven brokerages that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has issued a strong […]
Xponential Fitness, Inc. (XPOF) – What Are Investment Firms Saying About This Stock?
Shares of Xponential Fitness, Inc. (NYSE:XPOF – Get Free Report) have been assigned an average rating of “Hold” from the twelve research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, ten have issued a hold recommendation and one has given a buy […]
Peapack-Gladstone Financial Corporation (PGC) – What Are Investment Firms Saying About This Stock?
Peapack-Gladstone Financial Corporation (NASDAQ:PGC – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five ratings firms that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month […]
Turn Therapeutics Inc. (TTRX) – What Are Researchers Saying About This Stock?
Turn Therapeutics Inc. (NASDAQ:TTRX – Get Free Report) has been given an average rating of “Moderate Buy” by the six research firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, one has assigned a buy recommendation and two have assigned […]
Community West Bancshares (CWBC) – What Are Analysts Saying About This Stock?
Community West Bancshares (NASDAQ:CWBC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation […]
AppLovin Corporation (APP) – What Are Analysts Saying About This Stock?
AppLovin Corporation (NASDAQ:APP – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-eight analysts that are covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and three have given a strong buy rating to the company. […]
Bausch Health Cos Inc. (BHC) – What Are Analysts Saying About This Stock?
Bausch Health Cos Inc. (NYSE:BHC – Get Free Report) has earned a consensus rating of “Reduce” from the seven brokerages that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average 1-year price objective among […]
Cohu, Inc. (COHU) – What Are Investment Firms Saying About This Stock?
Shares of Cohu, Inc. (NASDAQ:COHU – Get Free Report) have received an average rating of “Moderate Buy” from the ten analysts that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, seven have assigned a buy recommendation and one has assigned […]
CaixaBank, S.A. Unsponsored ADR (CAIXY) – What Are Analysts Saying About This Stock?
Shares of CaixaBank, S.A. Unsponsored ADR (OTCMKTS:CAIXY – Get Free Report) have been assigned a consensus rating of “Hold” from the six analysts that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy […]
Spin Master Corp. (TOY.TO) – What Are Analysts Saying About This Stock?
Shares of Spin Master Corp. (TSE:TOY – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight analysts that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target […]
Fiverr International (FVRR) – What Are Investment Firms Saying About This Stock?
Fiverr International (NYSE:FVRR – Get Free Report) has earned a consensus rating of “Reduce” from the twelve analysts that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation and eleven have issued a hold recommendation on the company. The average 1 year price objective among brokerages that […]
Siemens AG (SIEGY) – What Are Researchers Saying About This Stock?
Siemens AG (OTCMKTS:SIEGY – Get Free Report) has earned an average rating of “Hold” from the eleven ratings firms that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, four have given a hold recommendation, four have assigned a buy recommendation and one has given a […]
Kyverna Therapeutics, Inc. (KYTX) – What Are Analysts Saying About This Stock?
Shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) have been given an average rating of “Moderate Buy” by the seven analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have given a buy rating and one has given a strong […]
Amcor PLC (AMCR) – What Are Investment Firms Saying About This Stock?
Shares of Amcor PLC (NYSE:AMCR – Get Free Report) have received a consensus rating of “Moderate Buy” from the twelve research firms that are currently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong […]
Crescent Biopharma, Inc. (CBIO) – What Are Researchers Saying About This Stock?
Shares of Crescent Biopharma, Inc. (NASDAQ:CBIO – Get Free Report) have been given an average recommendation of “Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have issued a buy rating and two have issued a strong buy […]
Spyre Therapeutics, Inc. (SYRE) – What Are Analysts Saying About This Stock?
Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seventeen analysts that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have issued a buy rating […]
last updated on 16 Nov 20:22